More news about Embion Technologies
Company profiles on startup.ch

Seed financing enables Embion to proceed towards commercialization

05.04.2019 13:11

Related tags

Earth

Embion Technologies SA, a Swiss EPFL spin-off in the rapidly growing field of prebiotics, successfully closed a seed round with renowned investors. The company was able to attract strategic investors from from Switzerland, United States and Asia alongside the existing shareholders, confirming the company’s ambition to become the relevant global player in its field.

Embion revolutionizes the use of plant biomass as a resource for the extraction of functional ingredients using novel, patented technology. The raised capital will be used to enhance the market entry and scalability of Embion Technologies focusing on prebiotics; natural plant extracts that can modulate the human and animal microbiome. The microbiome, the trillions of microscopic organisms that live within the human and animal body, have recently attracted the attention of the global scientific community, discovering evidence of their link to the immune system, brain functions and metabolism, connecting with disease such as obesity, IBS, autism, stress and cancer to name only a few.

Although new, the prebiotics market is rapidly growing. A new market study by New Hope Network shows that prebiotics are the hottest microbiome ingredients at the moment, having had three consecutive years of doubling sales and growth of more than 120 percent.

Georgios Savoglidis, CEO of Embion Technologies, stated: “2018 was a year that we made considerable progress in all aspects of the business and this is reflected in the trust that our investors put in us. The interest in our financing round was very high, we had to turn down some very attractive options on the way. But at this early stage of the business it is key to have the right people on board and that there is full alignment of expectations. Our focus now is to reach commercialization in the first identified market of prebiotics within the following months.”

Andreas Weckherlin who will join the board of directors commented “Embion is uniquely positioned with an outstanding innovation for a phase of high growth. We are impressed by Embion’s Team and expertise to make a difference in its field.” Stephane Constant, CEO of Solevo Group Switzerland, will also join Embion’s board. He commented: “Embion Technologies’ team is working on a real breakthrough in the field of renewable resources, with the vision to extract value ingredients from our natural resources, including the huge pile that is currently wasted, at affordable costs.”

(Press release)
Picture: Gerd Altmann, Pixabay

Please login or
register to comment

Please login or sign up to comment. Commenting guidelines

More news about Embion Technologies
Company profiles on startup.ch
Please login or
register to use the
bookmark feature

Related News

Related tags

Read more about

Please login or
register to comment

Please login or sign up to comment. Commenting guidelines

 

Principal

A showcase for female CEOs



Startupticker has recorded Swiss start-ups with female CEOs and ranked them by sector. The map which includes links to 80+ companies can be downloaded in our article.

 

Partners

Contributors

By continuing to use this website you agree with our TERMS AND CONDITIONS